Next report date
≈
August 28
Report period
H1 2025
EPS estimate
0.01 EUR
Revenue estimate
2.29 B EUR
0.0131 EUR
241.27 M EUR
3.89 B EUR
9.47 B
About SINO BIOPHARMACEUTICAL
Sector
Industry
CEO
S Y Tse
Website
Headquarters
Hong Kong
Founded
2000
FIGI
BBG000CBMKG5
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Investment, Modernised Chinese Medicines and Chemical Medicines; and Others. The Investment segment offers long-term investments. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long-term investments. The Other segment includes a research and development sector, which provides services to third parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse Cheung Ling Cheng and on February 2, 2000, and is headquartered in Hong Kong.
3.5%
5.0%
6.5%
8.0%
9.5%
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
0.00
600.00 M
1.20 B
1.80 B
2.40 B
Revenue
Net income
Net margin %
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
0.00
500.00 M
1.00 B
1.50 B
2.00 B
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
0.00
500.00 M
1.00 B
1.50 B
2.00 B
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
0.00
500.00 M
1.00 B
1.50 B
2.00 B
Debt
Free cash flow
Cash & equivalents
No news here
Looks like there's nothing to report right now
Sino Biopharma- Double three in action. HKEX:1177
Current wave analysis suggests that the stock has already completed a regular flat and zig-zag action.
Price action suggest that the stock is heading for further downside correction as rising wedge formation gave some hint that the stock is losing its steam on bullish momentum.
Thursda
1177, Sino Biopharm - Trailing Stop and Ascending TriangleHKEX:1177
After our long entry on the head and shoulders of reversing, we are managing the position by gradually moving the stop profits below the last lows.
Currently an upward triangle is forming within our trailing stop, which if it broke the resistance level would probably further give a bullis
1177, Sino Biopharm - Trailing Stop after Breakingout on H&SHKEX:1177
Here too we continue to move the stop loss in trailing stop mode, until we reach our primary objective, that is Break Even Point, equal to the entry point plus commissions.
Remember that Risk Management and Position Sizing are the fundamental points to have a positive trading operation.
S
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SMZ1 is 0.4138 EUR — it has decreased by −0.53% in the past 24 hours. Watch SINO BIOPH.SUBDIV.HD-,025 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SINO BIOPH.SUBDIV.HD-,025 stocks are traded under the ticker SMZ1.
SMZ1 stock has risen by 2.10% compared to the previous week, the month change is a 3.87% rise, over the last year SINO BIOPH.SUBDIV.HD-,025 has showed a 16.20% increase.
We've gathered analysts' opinions on SINO BIOPH.SUBDIV.HD-,025 future price: according to them, SMZ1 price has a max estimate of 0.67 EUR and a min estimate of 0.36 EUR. Watch SMZ1 chart and read a more detailed SINO BIOPH.SUBDIV.HD-,025 stock forecast: see what analysts think of SINO BIOPH.SUBDIV.HD-,025 and suggest that you do with its stocks.
SMZ1 reached its all-time high on Jul 23, 2020 with the price of 1.2900 EUR, and its all-time low was 0.0015 EUR and was reached on Feb 26, 2009. View more price dynamics on SMZ1 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SMZ1 stock is 0.53% volatile and has beta coefficient of 1.11. Track SINO BIOPH.SUBDIV.HD-,025 stock price on the chart and check out the list of the most volatile stocks — is SINO BIOPH.SUBDIV.HD-,025 there?
Today SINO BIOPH.SUBDIV.HD-,025 has the market capitalization of 7.85 B, it has increased by 5.05% over the last week.
Yes, you can track SINO BIOPH.SUBDIV.HD-,025 financials in yearly and quarterly reports right on TradingView.
SINO BIOPH.SUBDIV.HD-,025 is going to release the next earnings report on Aug 28, 2025. Keep track of upcoming events with our Earnings Calendar.
SMZ1 earnings for the last half-year are 0.00 EUR per share, whereas the estimation was 0.01 EUR, resulting in a −62.50% surprise. The estimated earnings for the next half-year are 0.01 EUR per share. See more details about SINO BIOPH.SUBDIV.HD-,025 earnings.
SINO BIOPH.SUBDIV.HD-,025 revenue for the last half-year amounts to 1.72 B EUR, despite the estimated figure of 1.87 B EUR. In the next half-year revenue is expected to reach 2.29 B EUR.
SMZ1 net income for the last half-year is 46.83 M EUR, while the previous report showed 186.90 M EUR of net income which accounts for −74.94% change. Track more SINO BIOPH.SUBDIV.HD-,025 financial stats to get the full picture.
SINO BIOPH.SUBDIV.HD-,025 dividend yield was 2.19% in 2024, and payout ratio reached 65.98%. The year before the numbers were 1.44% and 35.95% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Mar 24, 2025, the company has 24.38 K employees. See our rating of the largest employees — is SINO BIOPH.SUBDIV.HD-,025 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SINO BIOPH.SUBDIV.HD-,025 EBITDA is 1.02 B EUR, and current EBITDA margin is 26.04%. See more stats in SINO BIOPH.SUBDIV.HD-,025 financial statements.
Like other stocks, SMZ1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SINO BIOPH.SUBDIV.HD-,025 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SINO BIOPH.SUBDIV.HD-,025 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SINO BIOPH.SUBDIV.HD-,025 stock shows the buy signal. See more of SINO BIOPH.SUBDIV.HD-,025 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.